HIV replication inhibitors (RiboTargets)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameHIV replication inhibitors (RiboTargets)
Drug Alias Nametat/TAR inhibitors (RiboTargets)HIV therapy (RiboTargets)RBT-158RBT-203
ClassificationSmall molecules
Mechanisms of ActionHuman Immunodeficiency Virus tat Gene Products inhibitorsHIV replication inhibitors
TargetsHuman Immunodeficiency Virus tat Gene Products
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesVernalis (Cambridge) LTD
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesVernalis (Cambridge) LTD
Active IndicationsN/A
Inactive IndicationsHIV Infections

Other Information

ATC CodeN/A
Related LinksN/A